Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Naftidrofuryl for acute stroke.

J Leonardi-Bee1, T Steiner, F Bath-Hextall

  • 1University of Nottingham, Division of Epidemiology and Public Health,Clinical Sciences Building, Nottingham City Hospital NHS Trust campus, Hucknall Road, Nottingham, UK NG5 1PB. jo.leonardi-bee@nottingham.ac.uk

The Cochrane Database of Systematic Reviews
|April 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the cost-effectiveness of mental health interventions for night-time economy workers.

Perspectives in public health·2025
Same author

[Palliative neurology].

Die Anaesthesiologie·2024
Same author

[Palliative neurology].

Der Nervenarzt·2024
Same author

Quantitative analysis of the impact of infectious disease physicians on patients in the emergency department fast-track parenteral antibiotics program.

BMC infectious diseases·2024
Same author

Inclusivity and decolonisation of the post-graduate public health curriculum: Reflections from a student-led approach.

Public health in practice (Oxford, England)·2024
Same author

Performance of commercial growing-finishing pigs fed supplemental isoquinoline alkaloids: a statistical process control analysis.

Porcine health management·2023
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Naftidrofuryl does not significantly reduce mortality or disability in acute stroke patients. Evidence is insufficient to support its use, with a trend towards increased minor adverse events.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Stroke is a leading cause of death and disability globally.
  • Effective treatments for acute stroke brain damage remain a critical unmet medical need.
  • Naftidrofuryl's efficacy in acute stroke is debated, necessitating a comprehensive evidence review.

Purpose of the Study:

  • To systematically evaluate the effectiveness of naftidrofuryl in the acute phase of stroke.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials.
  • Extensive database searches (Cochrane, MEDLINE, EMBASE, etc.) up to July 2006.
  • Inclusion of clinically diagnosed acute ischemic or hemorrhagic stroke patients.

Main Results:

  • Six trials with 1274 participants were analyzed.

Related Experiment Videos

  • No significant reduction in mortality (OR 1.03, 95% CI 0.78-1.36) or death/disability (OR 0.94, 95% CI 0.70-1.16) was observed.
  • A trend towards increased minor adverse events (OR 1.99, 95% CI 0.96-4.11) was noted, with no significant impact on blood pressure.

    • Conclusions:

    • Current evidence is insufficient to support the use of naftidrofuryl for acute stroke treatment.
    • Further research is needed to clarify potential benefits and risks.